Sridhar Gopal, Head of Business Development, International (JAPAC-EEMEA-LATAM), AbbVie
Sridhar Gopal Mandapati has over 25 years’ experience in the Pharma Industry, most of which has been in International Business Development across the world. He has led multiple billion dollar acquisitions, as well as, several global/regional in licensing deals and divestment projects across the globe.
He joined AbbVie Inc. in 2013 as the Director of Business Development & New Product Planning JAPAC. He was promoted to AbbVie’s Head of Business Development, International for JAPAC- EEMEA- LATAM in 2016.
Prior to AbbVie, Sridhar was with Astra Zeneca in both the United States and Asia as a Senior Director, Regional and Corporate Business Development in the Global Transaction Group.
Sridhar started his career in sales, marketing and in business development as a medical representative.
Sridhar graduated from the University of Bombay, India with his Masters in Marketing Management in 1996 and received his Bachelor’s Degree in Pharmaceutical Sciences from the University of Poona, India in 1991.